Description
Thirty percent of the global population have too much fat in their liver. The big question is: Are they really sick when most will not end up with liver disease?
This episode discusses:
- How should they be assessed and by whom?
- What does this mean to healthcare systems?
- Are there downsides to systematic screening?
Faculty
- Aleksander Krag (Moderator)
- Alina Allen (Faculty)
- Manal El-Sayed (Faculty)
- Ian Rowe (Faculty
Related episode
- EASL Studio Live from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclature
ℹ️ Please click here to watch this EASL Studio episode.
This EASL Studio is supported by an educational grant from NOVO NORDISK A/S.
